Screening and management of portal hypertension in advanced hepatocellular carcinoma: a French practice survey.

Fiche publication

Date publication

novembre 2022

Journal

Clinics and research in hepatology and gastroenterology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MANFREDI Sylvain

Tous les auteurs :
Allaire M, Manfredi S, Lerosey L, Ganne-Carrié N, Thabut D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36455860

Résumé

Portal hypertension (PHT) and hepatocellular carcinoma (HCC) are two major complications of cirrhosis that are closely linked and impact patients prognosis, particularly acute variceal bleeding (AVB). Therefore, PHT screening and AVB prophylaxis are major issues to improve the outcome of the patients, but practices may vary among physicians.